Sunshine Biopharma Inc. (SBFM)

HEALTH CARE: PHARMACEUTICALS
SIC: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

6500 TRANS-CANADA HIGHWAY POINTE-CLAIRE, QUEBEC, CANADA H9R 0A5

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer. Its product pipeline includes its lead compound, Difluoro-Etoposide, a multi-purpose anti-tumor compound targeted for various forms of cancer.

View SEC Filings from SBFM instead.

View recent insider trading info

Funds Holding SBFM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SBFM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SLILATY STEVE N. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
18,869,219 2019-09-02 1

MERZOUKI ABDERRAZZAK CHIEF OPERATING OFFICER

  • Officer
  • Director
18,850,000 2019-09-02 1

SEBAALY CAMILLE SECRETARY

  • Officer
  • Director
  • 10% Owner
29,861,719 2019-09-02 1

DI TURI MICHELE CO-CEO/PRESIDENT

  • Officer
  • Director
38,089,000 2018-08-23 0

ADVANOMICS CORP

  • 10% Owner
215,014,224 2016-10-10 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments